Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systematic amphetamine

This publication has 35 references indexed in Scilit:

• Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390
  European Journal of Pharmacology, 1988
• [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: Delineation of striosomal compartments and pallidal and nigral subdivisions
  Neuroscience, 1988
• The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand
  Neuroscience, 1988
• Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic amp-regulated phosphoprotein-32 immunoreactive neuronal structures and d1 receptor antagonist binding sites in various brain regions of the male rat—mismatches indicate a role of d1 receptors in volume transmission
  Neurochemistry International, 1988
• Topography of substantia nigra innervation by D1 receptor-containing striatal neurons
  Brain Research, 1987
• D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons
  Life Sciences, 1987
• Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain
  Journal of Neuroscience, 1986
• The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors
  European Journal of Pharmacology, 1986
• Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists
  European Journal of Pharmacology, 1986
• The pharmacological and anatomical substrates of the amphetamine response in the rat
  Brain Research, 1975